Skip to main content
# Title Department Research Member Research Year
61 Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells Department of Clinical Pathology Dr. Mohamed Galal Mostafa ELnaggar 2022
62 Evaluation of CD66c expression for minimal residual disease in precursor B acute lymphoblastic leukemia Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2022
63 Regulatory T-lymphocyte subsets in children with chronic immune thrombocytopenia after high-dose of dexamethasone Department of Clinical Pathology Dr. Noha gaber sayed 2022
64 Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt Department of Pediatric Oncology Prof. Douaa Mohamed Sayed Hussein 2022
65 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology maureen raafat 2022
66 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2022
67 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Department of Clinical Pathology Dr. Asmaa Mohamed Zahran Omar 2022
68 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
69 Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery Department of Anesthesia, Intensive care and Pain management Dr. Samar Muhammad mansour 2022
70 Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients Department of Cancer Biology Lamiaa Fadel Mohammed Abdelraheem 2022